Absci (ABSI) Cash from Financing Activities (2020 - 2026)

Absci (ABSI) reported Cash from Financing Activities of $7.6 million for Q1 2026, down 82.34% on a YoY basis from $42.8 million in Q1 2025, and up 96.67% sequentially from $3.8 million in Q4 2025.

Absci (ABSI) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Cash from Financing Activities data on file, last reported at $7.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 82.34% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at $70.7 million (up 60.21% YoY), and the FY2025 full-year result was $105.9 million, up 28.38% from the prior year.
  • Cash from Financing Activities improved to $7.6 million in Q1 2026, from $3.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $81.2 million in Q1 2024 to a low of -$1.2 million in Q4 2023.
  • A 5-year average of $11.6 million and a median of $490000.0 in 2024 frame the typical range for Cash from Financing Activities.
  • Peak annual rise in Cash from Financing Activities reached 12209.59% in 2025, while the deepest fall reached 649.25% in 2025.
  • Tracing ABSI's Cash from Financing Activities over 5 years: stood at $1.4 million in 2022, then tumbled by 188.66% to -$1.2 million in 2023, then soared by 179.84% to $986000.0 in 2024, then soared by 289.66% to $3.8 million in 2025, then jumped by 96.67% to $7.6 million in 2026.
  • Business Quant data shows ABSI's Cash from Financing Activities at $7.6 million in Q1 2026, $3.8 million in Q4 2025, and $60.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Absci 1.23 Bn 1.11 Bn - 7.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.56 Mn
Mar 31, 2026 7.56 Mn
Dec 31, 2025 3.84 Mn
Dec 31, 2025 3.84 Mn
Sep 30, 2025 60.32 Mn
Sep 30, 2025 60.32 Mn
Jun 30, 2025 -1.00 Mn
Jun 30, 2025 -1.00 Mn
Mar 31, 2025 42.79 Mn
Mar 31, 2025 42.79 Mn
Dec 31, 2024 986,000.00
Dec 31, 2024 986,000.00
Sep 30, 2024 490,000.00
Sep 30, 2024 490,000.00
Jun 30, 2024 -134,000.00
Jun 30, 2024 -134,000.00
Mar 31, 2024 81.18 Mn
Mar 31, 2024 81.18 Mn
Dec 31, 2023 -1.24 Mn
Dec 31, 2023 -1.24 Mn